...
首页> 外文期刊>International Journal of Pharmaceutics >In vitro drug release from acetylated high amylose starch-zein films for oral colon-specific drug delivery
【24h】

In vitro drug release from acetylated high amylose starch-zein films for oral colon-specific drug delivery

机译:从乙酰化高淀粉酱淀粉蛋白膜的体外药物释放用于口腔结肠特异性药物递送

获取原文
获取原文并翻译 | 示例

摘要

This study describes the preparation of free films of zein with and without acetylated high amylose maize starch (HAS) and their corresponding coated tablets as a novel approach to colonic drug delivery. We hypothesise that the embedding of a digestible starch component within the inert zein would allow the film to remain intact until the large intestine is reached. Free films of zein alone and starch/zein were prepared and characterized. SEM and AFM images of film surface showed that films were morphologically inhomogeneous, particularly at lower HAS/Zein ratios; however, nanothermal analysis data suggested that these differences in appearance within the same film are not compositional differences. Moreover, FT-IR could detect no molecular interaction between the two polymers. Paracetamol tablets were coated with HAS/Zein aqueous based coatings of different compositions to a TWG of 20%. Drug release from zein alone and 1:5 HAS/Zein coated tablets under upper gastrointestinal conditions (pH 1.2, pH 6.8 with pepsin and pancreatin included) was very similar (for example approximately 12% and 14% of the drug was released, respectively, after 6 h in a sequential in vitro test), suggesting that release in this region is limited and is not influenced by the presence of HAS in the ratio to zein under study. Studies using an in vitro colon model showed that under simulated colonic conditions, the drug release was significantly (p 0.05) more rapid from 1:5 HAS/Zein, compared to the zein alone coating formulation. These data therefore support the potential use of zein-starch mixed films for colonic targeting purposes.
机译:该研究描述了具有和没有乙酰化高直链淀粉玉米淀粉(HAS)和其相应的包衣片剂作为一种新的方法来结肠药物传递的玉米蛋白游离膜的制备。我们假设惰性玉米醇溶蛋白内消化的淀粉部件的嵌入将使直到到达大肠的电影保持不变。独自玉米醇溶蛋白和制备淀粉/玉米醇溶蛋白和特点的免费电影。膜表面的SEM和AFM图像显示,膜是不均匀的形态,特别是在较低HAS /玉米醇溶蛋白的比例;然而,nanothermal分析数据表明,同一膜内在外观这些差异是不组成差异。此外,FT-IR可以检测两种聚合物之间不存在分子相互作用。对乙酰氨基酚片剂用HAS /玉米蛋白水性不同的组合物的涂层,以20%的TWG。从单独和1玉米醇溶蛋白的药物释放:5具有/玉米醇溶蛋白涂覆的上胃肠条件下片剂(pH值1.2,pH 6.8的胃蛋白酶和包含胰酶)非常相似(例如约12%和药物的14%被释放时,分别在体外试验中的连续6小时)后,表明释放在该区域被限制,并且不被存在于所研究的比玉米醇溶蛋白已经影响。使用体外模型结肠研究表明,模拟结肠条件下,药物的释放是显著(P< 0.05)从1更快速:5 HAS /玉米醇溶蛋白,相比于单独的玉米蛋白包衣制剂。因此,这些数据支持了潜在用途用于结肠靶向的目的玉米醇溶蛋白 - 淀粉混合膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号